SLC25A26 and liver cancer: In the human clinical liver cancer tissues with high expression of SLC25A26, proliferation index Ki67 had low expression and the senescence markers p16, p21, and HMGA1 had high expression, and the tissues with low expression of SLC25A26 had opposite effects [28].